期刊文献+

钠/碘转运体的临床实用价值 被引量:1

Clinical value of sodium iodide symporter
暂未订购
导出
摘要 钠/碘转运体(sodium/iodidesymporter,NIS)是一种糖化膜蛋白,是甲状腺组织及非甲状腺组织摄取碘的分子基础。NIS不仅分布在甲状腺细胞基底膜上,也存在于胃、前列腺、子宫等组织中。通过增加或抑制其在甲状腺组织中的表达,可以诊断和治疗甲状腺疾病。另外,选择性地增加或导入NIS基因,利用放射性碘诊断和治疗非甲状腺肿瘤也显示出令人鼓舞的结果。NIS基因还可以作为影像报告基因,用以测定动物模型及转基因试验中目的基因的表达情况。所以,深入研究NIS,不仅有利于提高对甲状腺功能调控和甲状腺疾病的认识水平,而且具有十分重要的临床实用价值。 The sodium iodide symporter(NIS)is a membrane glycoprotein that mediates iodide uptake in the thyroid gland and several extrathyroidal tissues.In addition to thyroid tissues,the expression of NIS is found in stomach,prostate,placenta and so on.Radioiodine-concentrating activity in thyroid tissues has allowed the use of radioiodine as a diagnostic and therapeutic agent for patients with thyroid disorders.However,some extrathyroid tissues also take up radioiodine,contributing to unwanted side effects of radioiodine therapy.Now that the molecule of NIS has been cloned and characterized,it may be possible to develop novel strategies to differentially modulate NIS expression and activity,enhancing it in target tissues and impeding it in others.It is also important to explore the use of NIS as an imaging reporter gene to monitor the expression profile of the transgene in transgenic mouse animal models and in patients undergoing gene therapy clinical trials.
作者 李倩
机构地区 南京医科大学
出处 《国外医学(放射医学核医学分册)》 2003年第2期56-58,65,共4页 Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
关键词 糖化膜蛋白 钠/碘转运体 甲状腺疾病 诊断 治疗 sodium iodide symporter thyroid extrathyroidial tissue radioiodide therapy breast cancer gastric disease imaging reporter gene
  • 相关文献

参考文献13

  • 1Deleu S, Allory Y, Radulescu A, et al. Characterization of autonomous thyroid adenoma: metabolism gene expressionand pathology [J]. Thyroid, 2000, 10: 131-140.
  • 2Fujiwara H, Tatsumi K, Tanaka S, et al. A novel V59E missense mutation in the sodium iodide symporter gene in a family with iodide transport defect [J]. Thyroid, 2000, 10(6):471---474.
  • 3Lev O, De La Vieja, Levy D, et al. Identification of a structural requirement for thyroidal Na+/I-symporter (NIS) function from analysis of a mutation that causes human congenital hypothyroidism [J]. FEBS LETT, 1998, 429: 36-40.
  • 4Ajjan RA, Findlay C, Metcalfe RA, et al. The modulation of the human sodium iodide symporter activity by Graves'disease [J]. J Clin Endocrinol Metab, 1998, 83: 1217-1221.
  • 5Arturi F, Russo K, Schlumberger M, et al. Iodide symporter gene expression in human thyroid tumors [J]. J Clin Endocrino Metab, 1998, 83: 2493-2496.
  • 6Schmutzler C, Winzer R, Meissner-Weigl J, et al. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells [J]. Biochem Biophys Res Commun, 1997, 240: 832.
  • 7Kogai T, Schultz JJ, Johnson IS, et al. Retnoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in MCF-7 breast cell line [J]. Proc Natl Acad Sci USA, 2000, 97: 8519-8524.
  • 8Patricelli A J, Lappin MR, Steyn PF, et al. Mammary gland uptake of sodium Tc-pertechnetate in a cat with a drug-induced gynecomastia [J]. Vet Radiol ULtrasound, 1999, 40: 87-88.
  • 9Cho JY, Leveille R, Kao R, et al. Hormonal regulation of radioiodide uptake activity and Na^+/I- symporter expression in mammary glands [J]. J Clin Endocrinol Metab, 2000, 85: 2936-2943.
  • 10Tazebay UH, Wapnir IL, Levy O, et al. The mammary gland iodine transporter is expressed during lactation and in breast cancer [J]. Nat Med, 2000, 6: 871-878.

同被引文献4

  • 1Gr u ning T, tlepolts C,Zphel K,et al. Retlnoic acid for rediffer-en-tiation of thyroid cancer-does it hold its promise. Eur J Endocrinol,2003, 148(4) :395-402.
  • 2Schmutzler C, Hoang-Vu C, Ruger B, et al. Human thyroid cancinoma cell lines show different retinoic acid receptor repertoires and retinoid responses. Eur J Endocfinol, 2004,150(4) :547-556.
  • 3Simon D, Korber C, Krausch M, et al. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer:final results of a pilot study. Eur J Nucl Med Mol Imaging,2002,29(6) :775-782.
  • 4Haugen BR, Larson LL,Pugazhenthi U, et al. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids. J clin Endocrinol Metab ,2004,89:272-280.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部